AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients
Release Date:
AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients following Local Therapy with Curative Intent
CME Available: https://auau.auanet.org/node/38312
CME Expiration Date: May, 2024
ACKNOWLEDGEMENTS
Independent educational grant support provided by:
Astellas
AstraZeneca
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Lantheus Medical Imaging
Merck & Co., Inc.
Pfizer, Inc.
AUA2023: How to use PSMA-PET/CT in the Management of Relapsing Prostate Cancer Patients